Related Experiment Videos
Hypothyroidism and hyperthyroidism in major depression revisited
M Fava1, L A Labbate, M E Abraham
1Depression Research Program, Massachusetts General Hospital, Boston 02114, USA.
The Journal of Clinical Psychiatry
|May 1, 1995
Summary
Thyroid abnormalities are rare in depressed outpatients and do not affect treatment outcomes with fluoxetine. This study found no link between thyroid function and depression symptom improvement.
Area of Science:
- Endocrinology
- Psychiatry
- Clinical Research
Background:
- Thyroid dysfunction is sometimes associated with mood disorders.
- The prevalence of thyroid abnormalities in major depressive disorder requires further investigation.
- Understanding this relationship can inform treatment strategies.
Purpose of the Study:
- To determine the frequency of thyroid abnormalities in outpatients with major depression.
- To assess if thyroid hormone levels influence the response to antidepressant treatment.
- To evaluate the impact of thyroid function on depression symptom severity.
Main Methods:
- Screened 200 outpatients (18-65 years) meeting DSM-III-R criteria for major depression.
- Assessed thyroid indices including T3, T4, FT4I, T3U, and TSH.
- Treated 166 patients with fluoxetine for 12 weeks, monitoring depressive symptoms via HAM-D-17.
Main Results:
- No cases of clinical hyperthyroidism or hypothyroidism were identified.
- Slightly elevated TSH (2.6%) and subnormal T3/T3U levels were observed in a small percentage of patients.
- No correlation was found between thyroid test results and treatment response or symptom improvement.
Conclusions:
- Hypothyroidism and hyperthyroidism are uncommon in major depressive disorder outpatients.
- Subtle thyroid function variations do not appear to impact the effectiveness of fluoxetine treatment.
- Thyroid screening may not be essential for all depressed patients initiating antidepressant therapy.